Sophie Dimonaco
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies 6
- Otitis Media and Relapsing Polychondritis 5
- Urticaria and Related Conditions 4
- Genetics top 2%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 8
- Chronic Lymphocytic Leukemia Research 2
-
- Vasculitis and related conditions 11
- Nephrology top 5%
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research 3
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Neil CollinsonKatie TuckwellJohn H. StoneMicki KlearmanDaniël BlockmansBhaskar DasguptaJürgen RechMaría C. Cid
- Journals
- New England Journal of Medicine (1 paper)Annals of the Rheumatic Diseases (8 papers)Investigative Ophthalmology & Visual Science (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Sophie Dimonaco
17 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Rheumatology 921
- Genetics 396
- Pulmonary and Respiratory Medicine 861
- Nephrology 115
- Hematology 179
Countries citing papers authored by Sophie Dimonaco
This map shows the geographic impact of Sophie Dimonaco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Dimonaco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Dimonaco more than expected).
Fields of papers citing papers by Sophie Dimonaco
This network shows the impact of papers produced by Sophie Dimonaco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Dimonaco. The network helps show where Sophie Dimonaco may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sophie Dimonaco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 62 | |
| 2 | 2019 | 32 | |
| 3 | 2019 | 2 | |
| 4 | 2019 | 66 | |
| 5 | 2018 | 62 | |
| 6 | 2018 | 1 | |
| 7 | 2018 | 2 | |
| 8 | Trial of Tocilizumab in Giant-Cell Arteritisbreakdown → | 2017 | 815 |
| 9 | 2017 | 63 | |
| 10 | 2017 | 2 | |
| 11 | 2017 | 59 | |
| 12 | Baseline data on patients enrolled in a randomized, double-masked trial of tocilizumab in giant cell arteritis | 2016 | 1 |
| 13 | 2016 | 54 | |
| 14 | 2016 | 66 | |
| 15 | 2016 | 4 | |
| 16 | 2015 | 143 | |
| 17 | 2014 | 1 | |
| 18 | 2013 | 21 |
About Sophie Dimonaco
Sophie Dimonaco is a scholar working on Rheumatology, Genetics and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Vasculitis and related conditions (11 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers), Otitis Media and Relapsing Polychondritis (5 papers), Urticaria and Related Conditions (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Rheumatology (921 citations), Genetics (396 citations) and Pulmonary and Respiratory Medicine (861 citations). Sophie Dimonaco has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Neil Collinson, Katie Tuckwell, John H. Stone, Micki Klearman, Daniël Blockmans, Bhaskar Dasgupta, Jürgen Rech, María C. Cid, Elisabeth Brouwer and Carlo Salvarani. Their work appears in journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and Investigative Ophthalmology & Visual Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.